Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6 Pt 1
|
pubmed:dateCreated |
1998-8-6
|
pubmed:abstractText |
The glucose-6-phosphatase (G-6-Pase) system catalyzes the terminal enzymatic step of gluconeogenesis and glycogenolysis. Inhibition of the G-6-Pase system in the liver is expected to result in a reduction of hepatic glucose production irrespective of the relative contribution of gluconeogenesis or glycogenolysis to hepatic glucose output. In isolated perfused rat liver, S-3483, a derivative of chlorogenic acid, produced concentration-dependent inhibition of gluconeogenesis and glycogenolysis in a similar concentration range. In fed rats, glucagon-induced glycogenolysis resulted in hyperglycemia for nearly 2 h. Intravenous infusion of 50 mg . kg-1. h-1 S-3483 prevented the hyperglycemic peak and subsequently caused a further lowering of blood glucose. In 24-h starved rats, in which normoglycemia is maintained predominantly by gluconeogenesis, intravenous infusion of S-3483 resulted in a constant reduction of blood glucose levels. Intrahepatic concentrations of glucose-6-phosphate (G-6-P) and glycogen were significantly increased at the end of both in vivo studies. In contrast, lowering of blood glucose in starved rats by 3-mercaptopicolinic acid was accompanied by a reduction of G-6-P and glycogen. Our results demonstrate for the first time in vivo a pharmacologically induced suppression of hepatic G-6-P activity with subsequent changes in blood glucose levels.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/3-mercaptopicolinic acid,
http://linkedlifedata.com/resource/pubmed/chemical/Blood Glucose,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclohexanecarboxylic Acids,
http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Glucose-6-Phosphatase,
http://linkedlifedata.com/resource/pubmed/chemical/Glucose-6-Phosphate,
http://linkedlifedata.com/resource/pubmed/chemical/Glycogen,
http://linkedlifedata.com/resource/pubmed/chemical/Picolinic Acids,
http://linkedlifedata.com/resource/pubmed/chemical/S 3483
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0002-9513
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
274
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
G1087-93
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9696709-Animals,
pubmed-meshheading:9696709-Blood Glucose,
pubmed-meshheading:9696709-Cyclohexanecarboxylic Acids,
pubmed-meshheading:9696709-Enzyme Inhibitors,
pubmed-meshheading:9696709-Gluconeogenesis,
pubmed-meshheading:9696709-Glucose-6-Phosphatase,
pubmed-meshheading:9696709-Glucose-6-Phosphate,
pubmed-meshheading:9696709-Glycogen,
pubmed-meshheading:9696709-Kinetics,
pubmed-meshheading:9696709-Liver,
pubmed-meshheading:9696709-Picolinic Acids,
pubmed-meshheading:9696709-Rats,
pubmed-meshheading:9696709-Rats, Sprague-Dawley,
pubmed-meshheading:9696709-Rats, Wistar
|
pubmed:year |
1998
|
pubmed:articleTitle |
Pharmacodynamic profile of a novel inhibitor of the hepatic glucose-6-phosphatase system.
|
pubmed:affiliation |
Hoechst Marion Roussel Deutschland GmbH, Frankfurt am Main, Germany.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|